Sandu Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Sandu Pharmaceuticals has a total shareholder equity of ₹405.9M and total debt of ₹633.0K, which brings its debt-to-equity ratio to 0.2%. Its total assets and total liabilities are ₹524.1M and ₹118.2M respectively. Sandu Pharmaceuticals's EBIT is ₹17.3M making its interest coverage ratio 28.4. It has cash and short-term investments of ₹12.1M.
Key information
0.2%
Debt to equity ratio
₹633.00k
Debt
| Interest coverage ratio | 28.4x |
| Cash | ₹12.06m |
| Equity | ₹405.93m |
| Total liabilities | ₹118.22m |
| Total assets | ₹524.15m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524703's short term assets (₹223.0M) exceed its short term liabilities (₹106.4M).
Long Term Liabilities: 524703's short term assets (₹223.0M) exceed its long term liabilities (₹11.8M).
Debt to Equity History and Analysis
Debt Level: 524703 has more cash than its total debt.
Reducing Debt: 524703's debt to equity ratio has reduced from 21.2% to 0.2% over the past 5 years.
Debt Coverage: 524703's debt is well covered by operating cash flow (1200.5%).
Interest Coverage: 524703's interest payments on its debt are well covered by EBIT (28.4x coverage).